Improved laboratory confirmation of heparin-induced thrombocytopenia type II: time course of antibodies and combination of antigen and biologic assays

We studied whether laboratory confirmation of heparin-induced thrombocytopenia (HIT) can be improved after antigen clearance by determining free antibody and combining the results of an antigenic and a biologic assay. Blood samples taken over 40 days in 14 patients with HIT with thromboembolism unde...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Harenberg, Job (VerfasserIn) , Wang, Lianchun (VerfasserIn) , Hoffmann, Ursula (VerfasserIn) , Huhle, Günter (VerfasserIn) , Feuring, Martin (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 03 January 2001
In: American journal of clinical pathology
Year: 2001, Jahrgang: 115, Heft: 3, Pages: 432-438
ISSN:1943-7722
DOI:10.1309/ET2W-5J8E-MFVU-QYAH
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1309/ET2W-5J8E-MFVU-QYAH
Volltext
Verfasserangaben:Job Harenberg, Lianchun Wang, Ursula Hoffmann, Günter Huhle, Martin Feuring
Beschreibung
Zusammenfassung:We studied whether laboratory confirmation of heparin-induced thrombocytopenia (HIT) can be improved after antigen clearance by determining free antibody and combining the results of an antigenic and a biologic assay. Blood samples taken over 40 days in 14 patients with HIT with thromboembolism underwent fluorescence-linked immunofiltration and the carbon 14-serotonin release assays.Of the 14 patients, 11 showed positive results in both assays at day 1 after stopping heparin. The 3 patients with negative results seroconverted in one or both assays during the subsequent 7 days. Combining the positive results of the assays increased the sensitivity from 85% at day 1 to 100% at day 7. Assay results became negative in all patients within 40 days. The platelet count normalized between days 2 and 9 after withdrawal of heparin. It is assumed that the free antibody can be detected after withdrawal of heparin and after clearance of the platelet factor 4-heparin complex in patients with HIT.
Beschreibung:Gesehen am 26.04.2022
Beschreibung:Online Resource
ISSN:1943-7722
DOI:10.1309/ET2W-5J8E-MFVU-QYAH